Skip to main content
SpringerLink
Log in

Rotavirus vaccines: benefits still outweigh risks

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. GlaxoSmithKline Inc.GSK Statement on FDA Advisory Committee Meeting on Rotavirus Vaccines. Media Release: 7 May 2010. Available from: URL: http://www.gsk.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotavirus vaccines: benefits still outweigh risks. React. Wkly. 1301, 5 (2010). https://doi.org/10.2165/00128415-201013010-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013010-00015

Keywords

Search

Navigation